Evidence map›Paper›PMID 39262759›Full record

ReviewAmerican journal of translational research2024

A dual analysis of bougie and stylet development trend and impact of Chinese regulations on medical devices innovation.

Kun-Zhi Zhang, Qing-Hua Wu, Yu-Xiang Wang, Jin-Tao Duan, Wen-Hui Guo, Qing-Lai Zang

Abstract readReview
In one paragraph

Review in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kun-Zhi ZhangZhejiang Center for Medical Device Evaluation, Zhejiang Medical Products Administration Hangzhou 310009, Zhejiang, The People's Republic of China.
Qing-Hua WuDepartment of Anesthesiology, The First Hospital of Putian City Putian 351100, Fujian, The People's Republic of China.
Yu-Xiang WangSchool of Health Science and Engineering, University of Shanghai for Science and Technology Shanghai 200093, The People's Republic of China.
Jin-Tao DuanSchool of Health Science and Engineering, University of Shanghai for Science and Technology Shanghai 200093, The People's Republic of China.
Wen-Hui GuoSchool of Anesthesiology, Second Military Medical University/Naval Medical University Shanghai 200433, The People's Republic of China.
Qing-Lai ZangSchool of Anesthesiology, Second Military Medical University/Naval Medical University Shanghai 200433, The People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical device research and development are characterized by high costs, extended timelines, inherent risks, and the necessity for interdisciplinary knowledge and skills. It is significantly influenced by policies, making the understanding of medical device innovation both important and challenging. This paper takes a dual approach to analyze medical device innovation. We reviewed representative clinical product of bougie and stylet and summarized the common characteristics and trend of these product. Innovations in these products often involve adding depth markings, replacing material and design structure, enhancing visualization, deciding between reusable or disposable designs, and integrating multi-functional features. This underscores the delicate balance between technological advancements and medical costs for widespread clinical applicability. We explored the guiding role of policy in medical device innovation, emphasizing its impact through an analysis of medical device regulations and policies in China. By offering insights from the perspectives of medical device companies and regulators, this paper aims to elucidate the critical aspects of medical device innovation, assisting researchers in mitigating risks during product development.

Indexed as

economic and costinnovationMedical devicepolicy impactregulatory assessment

Identifiers

PMID39262759
PMCPMC11384360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.